SCHEMBL2994532

SCHEMBL2994532

CCCOP(=O)(CC(C)=O)OCCC

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
CYP3A4 P08684 1/20 0.34
LPAR3 Q9UBY5 3/20 0.34
LPAR1 Q92633 2/20 0.34
LPAR2 Q9HBW0 2/20 0.34
ALDH1A1 P00352 3/20 0.33
CES2 O00748 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
PPARD Q03181 1/20 0.32
TSHR P16473 1/20 0.32
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17355671 0.87 CYP3A4 (0.52) CYP3A4LPAR3LPAR1LPAR2ALDH1A1
SCHEMBL246813 0.81 TSHR (0.52) ALDH1A1TDP1PPARDTSHRCA12
SCHEMBL17860961 0.80 MEN1 (0.34) MEN1KMT2ACYP3A4LPAR3LPAR1
SCHEMBL2990947 0.80 TDP1 (0.38) MEN1KMT2ACYP3A4LPAR3LPAR1
SCHEMBL11743230 0.80 BTN3A1 (0.37) MEN1KMT2ACYP3A4LPAR3LPAR1
SCHEMBL2237874 0.78 NAAA (0.36) MEN1KMT2ACYP3A4LPAR3LPAR1
SCHEMBL15951719 0.78 POLB (0.39) MEN1KMT2ACYP3A4LPAR3LPAR1
SCHEMBL2990566 0.78 PPARD (0.39) MEN1KMT2ACYP3A4LPAR3LPAR1
SCHEMBL17878616 0.77 MEN1 (0.32) MEN1KMT2ACYP3A4LPAR3LPAR1
SCHEMBL2351213 0.77 MGAM (0.43) CYP3A4ALDH1A1TDP1PPARDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2771380-B1 POLYURETHANE BASED MEMBRANES AND/OR SEPARATORS FOR ELECTROCHEMICAL CELLS LUBRIZOL ADVANCED MAT INC (US) 2018-12-05 EP disclosed
US-9771394-B2 Antimicrobial polymyxins for treatment of bacterial infections MICURX PHARMACEUTICALS, INC. (KY) 2017-09-26 US disclosed
EP-2771938-B1 POLYURETHANE BASED ELECTROLYTE SYSTEMS FOR ELECTROCHEMICAL CELLS LUBRIZOL ADVANCED MAT INC (US) 2017-08-09 EP disclosed
EP-2771928-B1 ELECTROCHEMICAL CELLS COMPRISING POLYURETHANE-BASED ELECTRODE BINDER COMPOSITIONS LUBRIZOL ADVANCED MAT INC (US) 2017-05-03 EP disclosed
US-9397337-B2 Polyurethane-based electrode binder compositions and electrodes thereof for electrochemical cells LUBRIZOL ADVANCED MATERIALS, INC. (US) 2016-07-19 US disclosed
US-20160185823-A1 ANTIMICROBIAL POLYMYXINS FOR TREATMENT OF BACTERIAL INFECTIONS MICURX PHARMACEUTICALS, INC. 2016-06-30 US disclosed
US-20150372349-A1 NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE UBE INDUSTRIES, LTD. (JP) 2015-12-24 US disclosed
US-20150372349-A1 NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE UBE INDUSTRIES, LTD. (JP) 2015-12-24 US disclosed
US-8962192-B2 Nonaqueous electrolytic solution and nonaqueous electrolyte battery MITSUBISHI CHEMICAL CORPORATION (JP) 2015-02-24 US disclosed
US-20140302398-A1 Polyurethane-Based Electrode Binder Compositions And Electrodes Thereof For Electrochemical Cells LUBRIZOL ADVANCED MATERIALS, INC. 2014-10-09 US disclosed
EP-1023746-A1 MIXTURES WITH SPECIAL SOFTENING AGENTS SUITED AS A SOLID ELECTROLYTE OR SEPARATOR FOR ELECTROCHEMICAL CELLS BASF AKTIENGESELLSCHAFT (DE) 2000-08-02 EP disclosed
WO-2000033406-A1 MEMBRANE SUITABLE FOR ELECTROCHEMICAL CELLS BASF AKTIENGESELLSCHAFT (DE) 2000-06-08 WO disclosed
WO-2000008068-A1 COMPOSITIONS SUITABLE FOR ELECTROCHEMICAL CELLS BASF AKTIENGESELLSCHAFT (DE) 2000-02-17 WO disclosed
EP-0970529-A1 METHOD FOR PRODUCING SHAPED BODIES FOR LITHIUM ION BATTERIES BASF AKTIENGESELLSCHAFT (DE) 2000-01-12 EP disclosed
WO-1999057161-A1 COMPOSITIONS SUITABLE FOR ELECTROCHEMICAL CELLS BASF AKTIENGESELLSCHAFT (DE) 1999-11-11 WO disclosed
WO-1999019921-A1 MIXTURES WITH Li-CONTAINING SOLIDS SUITABLE AS SOLID ELECTROLYTES OR SEPARATORS FOR ELECTROCHEMICAL CELLS BASF AKTIENGESELLSCHAFT (DE) 1999-04-22 WO disclosed
WO-1999018621-A1 MIXTURES WITH SPECIAL SOFTENING AGENTS SUITED AS A SOLID ELECTROLYTE OR SEPARATOR FOR ELECTROCHEMICAL CELLS BASF AKTIENGESELLSCHAFT (DE) 1999-04-15 WO disclosed
EP-0890196-A1 MIXTURES SUITABLE AS SOLID ELECTROLYTES OR SEPARATORS FOR ELECTROCHEMICAL CELLS BASF AKTIENGESELLSCHAFT (DE) 1999-01-13 EP disclosed
WO-1998044576-A1 METHOD FOR PRODUCING SHAPED BODIES FOR LITHIUM ION BATTERIES BASF AKTIENGESELLSCHAFT (DE) 1998-10-08 WO disclosed
WO-1997037397-A1 MIXTURES SUITABLE AS SOLID ELECTROLYTES OR SEPARATORS FOR ELECTROCHEMICAL CELLS BASF AKTIENGESELLSCHAFT (DE) 1997-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150372349-A1 NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE HCN2, SCO2, HCN1 MEN1 4646/4885KMT2A 2355/4885CYP3A4 3376/4885
US-20160185823-A1 ANTIMICROBIAL POLYMYXINS FOR TREATMENT OF BACTERIAL INFECTIONS VIP, AQP1, PEF1 MEN1 2965/4885KMT2A 4316/4885CYP3A4 3756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.